Add like
Add dislike
Add to saved papers

Antihyperglycemic, antilipid peroxidation, and insulin secretory activities of Otostegia persica shoot extract in streptozotocin-induced diabetic rats and in vitro C187 pancreatic β-cells.

Pharmaceutical Biology 2013 Februrary
CONTEXT: Otostegia persica Boiss (Lamiaceae) contains antioxidant agents and is used in traditional medicine for treatment of diabetes mellitus complications.

OBJECTIVES: The acute antihyperglycemic, antilipid peroxidation, and insulin secretory activities of methanol extract of O. persica aerial parts were investigated.

MATERIALS AND METHODS: The extract [200, 300, 400 mg/kg body weight (b.w.)] was given orally to rats and glucose (2 g/kg b.w. orally) was administered 30 min later. Glucose and insulin serum levels were measured before and 30, 60, 120, and 240 min after administration of the test samples in normal and diabetic rats. The in vitro insulin secretory activity of extract was evaluated in C187 pancreatic β-cells and its antilipid peroxidation effect was determined by measuring malondialdehyde (MDA) and glutathione (GSH) levels in rat livers after 240 min. The identification of the major phytoconstituents of the extract was carried out using gas chromatography-mass spectrometry.

RESULTS: The extract (300 mg/kg b.w.) significantly decreased the serum glucose level in diabetic rats at 1 h (494 ± 13.4 vs. 426 ± 12.9), 2 h (472.8 ± 17.8 vs. 396 ± 22), and 4 h (438.8 ± 25 vs. 346 ± 19) after treatment. Accordingly, the serum insulin level increased at the same times. The extract significantly increased glucose-induced insulin secretion in C187 β-cells. Moreover, the extract significantly decreased MDA and increased GSH levels in the liver of diabetic rats. Phytochemical analysis revealed thymol as the major phytoconstituent in the extract.

DISCUSSION AND CONCLUSION: O. persica shoot extract has antihyperglycemic, antilipid peroxidation, and insulin secretory properties.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app